Three-dimensional conformal hypofractionated simultaneous integrated boost in breast conserving therapy: Results on local control and survival-Reference-Cited by-同舟云学术

Three-dimensional conformal hypofractionated simultaneous integrated boost in breast conserving therapy: Results on local control and survival

Published:2011-08 Issue:2 Volume:100 Page:215-220
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Bantema-Joppe Enja J.,van der Laan Hans Paul,de Bock Geertruida H.,Wijsman Robin,Dolsma Wil V.,Busz Dianne M.,Langendijk Johannes A.,Maduro John H.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference26 articles.

1. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials;Clarke;Lancet,2005

2. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer;Fisher;N Engl J Med,2002

3. Landelijke werkgroep behandeling van het mammacarcinoom. Available from: http://www.oncoline.nl/index.php?pagina=/richtlijn/item/pagina.php&id=27539&richtlijn_id=593. Accessed September 4, 2010.

4. Current technological clinical practice in breast radiotherapy; results of a survey in EORTC-Radiation Oncology Group affiliated institutions;van der Laan;Radiother Oncol,2010

5. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial;Bartelink;J Clin Oncol,2007

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous integrated boost intensity-modulated radiotherapy post breast-conserving surgery: clinical efficacy, adverse effects, and cosmetic outcomes in breast cancer patients;Breast Cancer;2024-05-05

2. Compare the impact of simultaneous integrated boost radiotherapy and conventional radiotherapy with sequential boost to early breast cancer patients;Journal of Radiation Research and Applied Sciences;2023-09

3. Late Toxicities, Failure Patterns, Local Tumor Control, and Survival of Esophageal Squamous Cell Carcinoma Patients After Chemoradiotherapy With a Simultaneous Integrated Boost: A 5-Year Phase II Study;Frontiers in Oncology;2021-11-18

4. Patient-Specific Heart Constraint: A Tool for Optimization and Evaluation of Mean Heart Dose in Breast Cancer Patients;Practical Radiation Oncology;2021-03

5. Acute and intermediate toxicity of 3-week radiotherapy with simultaneous integrated boost using TomoDirect: prospective series of 287 early breast cancer patients;Clinical and Translational Oncology;2021-02-03